Cargando…

Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease

While a base substitution in intron 4 of GLA (IVS4+919G>A) that causes aberrant alternative splicing resulting in Fabry disease has been reported, its molecular mechanism remains unclear. Here we reported that upon IVS4+919G>A transversion, H3K36me3 was enriched across the alternatively splice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Wen-Hsin, Niu, Dau-Ming, Lu, Chi-Yu, Lin, Shyr-Yi, Liu, Ta-Chih, Chang, Jan-Gowth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400244/ https://www.ncbi.nlm.nih.gov/pubmed/28430823 http://dx.doi.org/10.1371/journal.pone.0175929

Ejemplares similares

Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016)

Assessment of Fabry variant (IVS4+919G>A) Cardiomyopathy in Taiwanese: Emphasis on T1 mapping
por: Chang, Yu-pin, et al.
Publicado: (2016)

Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)
por: Lin, Hsiang-Yu, et al.
Publicado: (2013)

MRI assessment of cardiomyopathy in Taiwan Chinese late-onset Fabry mutation (IVS4+919G>A)
por: Chang, Yu-Pin, et al.
Publicado: (2015)

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)
por: Hsu, Ting-Rong, et al.
Publicado: (2014)

Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey
por: Hsu, Ting-Rong, et al.
Publicado: (2017)

A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation
por: Lee, Han-Jui, et al.
Publicado: (2017)

Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations
por: Alfen, Franziska, et al.
Publicado: (2022)

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
por: Liu, Hao-Chuan, et al.
Publicado: (2014)

Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations
por: Ferri, Lorenzo, et al.
Publicado: (2016)

Fabry disease due to D313Y and novel GLA mutations
por: Koulousios, Konstantinos, et al.
Publicado: (2017)

Functional evaluation of a novel GLA causative mutation in Fabry disease
por: Li, Ping, et al.
Publicado: (2019)

Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease
por: Varela, Patrícia, et al.
Publicado: (2019)

Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5‐diamino‐6‐chloro‐N‐(N‐(2,6‐dichlorobenzoyl)carbamimidoyl)pyrazine‐2‐carboxide
por: Lee, Chien‐Chin, et al.
Publicado: (2019)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

4β-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells
por: Lee, Chien-Chin, et al.
Publicado: (2017)

Correction: Fabry disease due to D313Y and novel GLA mutations
Publicado: (2018)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
por: Dai, Xuantong, et al.
Publicado: (2022)

Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease
por: Song, Hui-Yung, et al.
Publicado: (2016)

Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells
por: Chang, Jan-Gowth, et al.
Publicado: (2011)

Fabry disease: Evidence for a regional founder effect of the GLA gene mutation 30delG in Brazilian patients
por: de Alencar, Dayse Oliveira, et al.
Publicado: (2014)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
por: Chaves-Markman, Ândrea Virgínia, et al.
Publicado: (2019)

Future clinical and biochemical predictions of Fabry disease in females by methylation studies of the GLA gene
por: Hossain, Mohammad Arif, et al.
Publicado: (2019)

Alternative splicing modulation by G-quadruplexes
por: Georgakopoulos-Soares, Ilias, et al.
Publicado: (2022)

Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease
por: Zhou, Chi, et al.
Publicado: (2018)

The potential consequences of bidirectional promoter methylation on GLA and HNRNPH2 expression in Fabry disease phenotypes in a family of patients carrying a GLA deletion variant
por: Al-Obaide, Mohammed A., et al.
Publicado: (2022)

Renal variant of Fabry disease with sporadic GLA gene mutation: role of early renal biopsy
por: Al-Salam, Suhail, et al.
Publicado: (2012)

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
por: Bittencourt, Marcelo Imbroinise
Publicado: (2019)

Identification of a Novel GLA Mutation (L206 P) in a Patient with Fabry Disease
por: Kim, Ji-Hoon, et al.
Publicado: (2017)

An Atypical Cardiac Manifestation of Fabry Disease from a Novel Pathological Variant on the GLA Gene
por: Sarsam, Luay, et al.
Publicado: (2020)

Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation
por: Valtola, Kati, et al.
Publicado: (2023)

Beam Disturbances during Run 919
por: Colchester, R J
Publicado: (1978)

All reported non-canonical splice site variants in GLA cause aberrant splicing
por: Okada, Eri, et al.
Publicado: (2023)

Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019)

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene
por: Lukas, Jan, et al.
Publicado: (2012)

Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
por: Oder, Daniel, et al.
Publicado: (2016)

Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related GLA-Variant p.A143T
por: Godel, Tim, et al.
Publicado: (2020)

Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
por: Kaneski, Christine R., et al.
Publicado: (2022)

The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants
por: Sánchez, Rosario, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5fpp27g0rh44jqep2u15fj95tg